110 related articles for article (PubMed ID: 23234860)
1. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival?
Mujar M; Dahlui M; Yip CH; Taib NA
Prev Med; 2013 Mar; 56(3-4):222-4. PubMed ID: 23234860
[TBL] [Abstract][Full Text] [Related]
2. Delays in time to treatment and survival impact in breast cancer.
Brazda A; Estroff J; Euhus D; Leitch AM; Huth J; Andrews V; Moldrem A; Rao R
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():291-6. PubMed ID: 20853049
[TBL] [Abstract][Full Text] [Related]
3. Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, Malaysia.
Taib NA; Akmal M; Mohamed I; Yip CH
Asian Pac J Cancer Prev; 2011; 12(2):345-9. PubMed ID: 21545192
[TBL] [Abstract][Full Text] [Related]
4. Adherence to quality indicators and survival in patients with breast cancer.
Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
[TBL] [Abstract][Full Text] [Related]
5. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer.
Richards MA; Smith P; Ramirez AJ; Fentiman IS; Rubens RD
Br J Cancer; 1999 Feb; 79(5-6):858-64. PubMed ID: 10070881
[TBL] [Abstract][Full Text] [Related]
6. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
7. Impact of breast surgery on survival in women presenting with metastatic breast cancer.
Pathy NB; Verkooijen HM; Taib NA; Hartman M; Yip CH
Br J Surg; 2011 Nov; 98(11):1566-72. PubMed ID: 21858791
[TBL] [Abstract][Full Text] [Related]
8. The effect of delays in treatment for breast cancer metastasis on survival.
Jung SY; Sereika SM; Linkov F; Brufsky A; Weissfeld JL; Rosenzweig M
Breast Cancer Res Treat; 2011 Dec; 130(3):953-64. PubMed ID: 21739101
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
12. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
14. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of delays in time to treatment in triple negative breast cancer.
Eastman A; Tammaro Y; Moldrem A; Andrews V; Huth J; Euhus D; Leitch M; Rao R
Ann Surg Oncol; 2013 Jun; 20(6):1880-5. PubMed ID: 23292484
[TBL] [Abstract][Full Text] [Related]
16. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
17. Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia.
Nordin N; Yaacob NM; Abdullah NH; Mohd Hairon S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):497-502. PubMed ID: 29480991
[TBL] [Abstract][Full Text] [Related]
18. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
19. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
20. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
